Tamer Aksoy

[89Zr]Zr-girentuximab for PET–CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial

Brian Shuch, Allan J. Pantuck, Jean‐Christophe Bernhard et al. · The Lancet Oncology · 2024 · 95 citations · Full text

Positron Emission Tomography, Urology, Engineering +13

Results from phase 3 study of ⁸⁹Zr-DFO-girentuximab for PET/CT imaging of clear cell renal cell carcinoma (ZIRCON).

Brian Shuch, Allan J. Pantuck, Jean‐Christophe Bernhard et al. · Journal of Clinical Oncology · 2023 · 36 citations

Surgical Oncology, Oncologic Imaging, Pet-mri +25

68Ga-FAPI-04 PET/CT in Selected Breast Cancer Patients With Low FDG Affinity

Göksel Alçın, Esra Arslan, Tamer Aksoy et al. · Clinical Nuclear Medicine · 2023 · 30 citations

<sup>68</sup>Ga-PSMA PET/CT Versus <sup>18</sup>F-FDG PET/CT for Imaging of Hepatocellular Carcinoma

Cihan Gündoğan, Nurhan Ergül, Mehmet Semih Çakır et al. · Molecular Imaging and Radionuclide Therapy · 2021 · 23 citations · Full text

Correlations between histopathologic and scintigraphic parameters of salivary glands in patients with Sjögren’s syndrome

Tamer Aksoy, Belkıs Erbaş · Clinical Rheumatology · 2012 · 20 citations

Sjögren’s Syndrome, Medicine, Systemic Scleroderma +8